Picture of Charming Medical logo

MCTA — Charming Medical Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Charming Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUS20-F
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-0.3360.8221.2-0.023
Depreciation
Deferred Taxes
Non-Cash Items0.061-0.037-0.011-0.058
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.58-0.943-1.16-1.42
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities2.430.2950.426-1.22
Capital Expenditures-0.606-0.211-0.288-0.34
Purchase of Fixed Assets
Other Investing Cash Flow Items——-1.940.161
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.606-0.211-2.23-0.179
Financing Cash Flow Items-1.250.2160.472-0.999
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1.430.10.5215.29
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.4030.174-1.293.88